Leonhard Müllauer

22PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Haematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 27, 2025
Therapeutic Effects of Lurbinectedin in PARP Inhibitor-Resistant High-Grade Serous Ovarian Cancer Using Patient-Derived Cell Lines and Organoid Models.

Akshi Srivastava, Christine Unterweger, Sarah Guttmann

|Mar 13, 2025
ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer.

Valentina Glueck, Christoph Grimm, Magdalena Postl

|Mar 11, 2025
The atypical KRASQ22K mutation directs TGF-β response towards partial epithelial-to-mesenchymal transition in patient-derived colorectal cancer tumoroids.

Theresia Mair, Philip König, Milena Mijović

|Apr 21, 2024
Nfe2l2/NRF2 Deletion Attenuates Tumorigenesis and Increases Bacterial Diversity in a Mouse Model of Lynch Syndrome.

Felix Haller, Kristine Jimenez, Maximilian Baumgartner

|May 13, 2023
Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR.

Natalia Stepien, Daniel Senfter, Julia Furtner

|Apr 10, 2023
Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer.

Erwin Tomasich, Ariane Steindl, Christina Paiato

Pageof 4

Frequent Collaborators

5 joint publications

Christoph Grimm

3 joint publications

Amedeo A Azizi

3 joint publications

Johannes Gojo

3 joint publications

Walter Berger